Peer-influenced content. Sources you trust. No registration required. This is HCN.
Health
The presence of small stones in processed chocolate products highlights vulnerabilities in food manufacturing quality control systems, particularly in handling of natural ingredients like almonds.
All Specialties May 1st 2025
Manufacturing deficiencies included inadequate contamination prevention and quality control measures, with historical context of previous recalls from the same facility that were associated with patient adverse events.
Allergy & Immunology April 30th 2025
MedCentral
Unacceptable levels of N-nitroso atomoxetine, a potential carcinogen, were found in multiple atomoxetine batches, according to the FDA.
Clinical Pharmacology April 1st 2025
The FDA gave the recall a class 2 risk level, meaning that drinking the creamers ‘may cause temporary or medically reversible adverse health consequences,’ or that the possibility of serious health consequences is ‘remote.’
Emergency Medicine March 31st 2025
MDLinx
Healthcare providers should be vigilant for patients presenting with neurological symptoms, especially if there’s a history of consuming canned tuna products.
Emergency Medicine March 12th 2025
N-nitroso-duloxetine poses increased cancer risk at higher concentrations and extended exposure periods, prompting FDA-mandated strict limits on nitrosamine levels in medications.
Family Medicine/General Practice January 8th 2025